A Phase 3 interventional study of incisional hernia repair in Postoperative Pain, Complications and Recurrence, sponsored by Erasmus Medical Center. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-08-22.
Sponsored by Erasmus Medical Center · Phase 3, Interventional, and Treatment
Primary closure of incisional hernia without the use of a mesh shows recurrence rates of up to 54%. If a mesh is used, the defect can be closed tension-free. Using this method, recurrence rates have been reduced to 8-21%. Laparoscopic correction of incisional hernia is a relatively new technique in which the mesh is positioned intraperitoneally. Research has shown that this procedure is technical feasible and may have benefits for the patients.
The ongoing debate about the merits of endoscopic versus open incisional hernia repair prompts the need for a level 1 randomized controlled trial.
4,279 studies on the registry are indexed under Recurrence; 988 are open to participants now.
This study's enrollment of 206 is above the median of 50 across 3,374 interventional studies indexed under Recurrence.
Browse Recurrence studies →Erasmus Medical Center is the lead sponsor of 466 studies on the registry; 179 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
open incisional hernia repair
Procedure: incisional hernia repair
laparoscopic incisional hernia repair
Procedure: incisional hernia repair
Tension-free open or laparoscopic incisional hernia repair
Postoperative pain
Time frame: 4 weeks
Postoperative analgesics use
Time frame: 1 week
complications
Time frame: 4 weeks
operation time
Time frame: 1 day
length of hospital stay
Time frame: 4 weeks
recurrence
Time frame: 5 years
mortality
Time frame: 5 years
No study locations are listed for this record.
This study is completed, as verified in Aug 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Erasmus Medical Center